Literature DB >> 25349167

Towards a classification of biomarkers of neuropsychiatric disease: from encompass to compass.

J Davis1, M Maes1, A Andreazza2, J J McGrath3, S J Tye4, M Berk5.   

Abstract

There is currently considerable imprecision in the nosology of biomarkers used in the study of neuropsychiatric disease. The neuropsychiatric field lags behind others such as oncology, wherein, rather than using 'biomarker' as a blanket term for a diverse range of clinical phenomena, biomarkers have been actively classified into separate categories, including prognostic and predictive tests. A similar taxonomy is proposed for neuropsychiatric diseases in which the core biology remains relatively unknown. This paper divides potential biomarkers into those of (1) risk, (2) diagnosis/trait, (3) state or acuity, (4) stage, (5) treatment response and (6) prognosis, and provides illustrative exemplars. Of course, biomarkers rely on available technology and, as we learn more about the neurobiological correlates of neuropsychiatric disorders, we will realize that the classification of biomarkers across these six categories can change, and some markers may fit into more than one category.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25349167     DOI： 10.1038/mp.2014.139

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN： 1359-4184            Impact factor:   15.992


  10 in total

1.  A systemic toxicity index developed to assess peripheral changes in mood episodes.

Authors:  F Kapczinski; F Dal-Pizzol; A L Teixeira; P V S Magalhaes; M Kauer-Sant'Anna; F Klamt; M A de Bittencourt Pasquali; J Quevedo; C S Gama; R Post
Journal:  Mol Psychiatry       Date:  2010-03-30       Impact factor: 15.992

2.  Decreased peripheral brain-derived neurotrophic factor levels are a biomarker of disease activity in major psychiatric disorders: a comparative meta-analysis.

Authors:  B S Fernandes; M Berk; C W Turck; J Steiner; C-A Gonçalves
Journal:  Mol Psychiatry       Date:  2013-12-17       Impact factor: 15.992

Review 3.  Depression: an inflammatory illness?

Authors:  Rajeev Krishnadas; Jonathan Cavanagh
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-03-15       Impact factor: 10.154

4.  Identification of a biological signature for schizophrenia in serum.

Authors:  E Schwarz; P C Guest; H Rahmoune; L W Harris; L Wang; F M Leweke; M Rothermundt; B Bogerts; D Koethe; L Kranaster; P Ohrmann; T Suslow; G McAllister; M Spain; A Barnes; N J M van Beveren; S Baron-Cohen; J Steiner; F E Torrey; R H Yolken; S Bahn
Journal:  Mol Psychiatry       Date:  2011-04-12       Impact factor: 15.992

5.  Resting leukocyte telomerase activity is elevated in major depression and predicts treatment response.

Authors:  O M Wolkowitz; S H Mellon; E S Epel; J Lin; V I Reus; R Rosser; H Burke; M Compagnone; J C Nelson; F S Dhabhar; E H Blackburn
Journal:  Mol Psychiatry       Date:  2011-01-18       Impact factor: 15.992

6.  Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study.

Authors:  P Lewczuk; H Kamrowski-Kruck; O Peters; I Heuser; F Jessen; J Popp; K Bürger; H Hampel; L Frölich; S Wolf; B Prinz; H Jahn; Ch Luckhaus; R Perneczky; M Hüll; J Schröder; H Kessler; J Pantel; H-J Gertz; H-W Klafki; H Kölsch; U Reulbach; H Esselmann; J M Maler; M Bibl; J Kornhuber; J Wiltfang
Journal:  Mol Psychiatry       Date:  2008-07-29       Impact factor: 15.992

7.  Variant GADL1 and response to lithium therapy in bipolar I disorder.

Authors:  Chien-Hsiun Chen; Chau-Shoun Lee; Ming-Ta Michael Lee; Wen-Chen Ouyang; Chiao-Chicy Chen; Mian-Yoon Chong; Jer-Yuarn Wu; Happy Kuy-Lok Tan; Yi-Ching Lee; Liang-Jen Chuo; Nan-Ying Chiu; Hin-Yeung Tsang; Ta-Jen Chang; For-Wey Lung; Chen-Huan Chiu; Cheng-Ho Chang; Ying-Sheue Chen; Yuh-Ming Hou; Cheng-Chung Chen; Te-Jen Lai; Chun-Liang Tung; Chung-Ying Chen; Hsien-Yuan Lane; Tung-Ping Su; Jung Feng; Jin-Jia Lin; Ching-Jui Chang; Po-Ren Teng; Chia-Yih Liu; Chih-Ken Chen; I-Chao Liu; Jiahn-Jyh Chen; Ti Lu; Chun-Chieh Fan; Ching-Kuan Wu; Chang-Fang Li; Kathy Hsiao-Tsz Wang; Lawrence Shih-Hsin Wu; Hsin-Ling Peng; Chun-Ping Chang; Liang-Suei Lu; Yuan-Tsong Chen; Andrew Tai-Ann Cheng
Journal:  N Engl J Med       Date:  2013-12-25       Impact factor: 91.245

8.  Antenatal prediction of postpartum depression with blood DNA methylation biomarkers.

Authors:  J Guintivano; M Arad; T D Gould; J L Payne; Z A Kaminsky
Journal:  Mol Psychiatry       Date:  2013-05-21       Impact factor: 15.992

9.  Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder.

Authors:  C D Rethorst; M S Toups; T L Greer; P A Nakonezny; T J Carmody; B D Grannemann; R M Huebinger; R C Barber; M H Trivedi
Journal:  Mol Psychiatry       Date:  2012-08-28       Impact factor: 15.992

10.  Molecular genetic evidence for overlap between general cognitive ability and risk for schizophrenia: a report from the Cognitive Genomics consorTium (COGENT).

Authors:  T Lencz; E Knowles; G Davies; S Guha; D C Liewald; J M Starr; S Djurovic; I Melle; K Sundet; A Christoforou; I Reinvang; S Mukherjee; Pamela DeRosse; A Lundervold; V M Steen; M John; T Espeseth; K Räikkönen; E Widen; A Palotie; J G Eriksson; I Giegling; B Konte; M Ikeda; P Roussos; S Giakoumaki; K E Burdick; A Payton; W Ollier; M Horan; G Donohoe; D Morris; A Corvin; M Gill; N Pendleton; N Iwata; A Darvasi; P Bitsios; D Rujescu; J Lahti; S L Hellard; M C Keller; O A Andreassen; I J Deary; D C Glahn; A K Malhotra
Journal:  Mol Psychiatry       Date:  2013-12-17       Impact factor: 15.992
  10 in total
  37 in total

Review 1.  Dispositional negativity: An integrative psychological and neurobiological perspective.

Authors:  Alexander J Shackman; Do P M Tromp; Melissa D Stockbridge; Claire M Kaplan; Rachael M Tillman; Andrew S Fox
Journal:  Psychol Bull       Date:  2016-10-10       Impact factor: 17.737

2.  Contributions of the Central Extended Amygdala to Fear and Anxiety.

Authors:  Alexander J Shackman; Andrew S Fox
Journal:  J Neurosci       Date:  2016-08-03       Impact factor: 6.167

Review 3.  White Matter-Based Structural Brain Network of Major Depression.

Authors:  Taolin Chen; Ziqi Chen; Qiyong Gong
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications.

Authors:  B S Fernandes; J Steiner; H-G Bernstein; S Dodd; J A Pasco; O M Dean; P Nardin; C-A Gonçalves; M Berk
Journal:  Mol Psychiatry       Date:  2015-07-14       Impact factor: 15.992

Review 5.  Peripheral blood brain-derived neurotrophic factor in bipolar disorder: a comprehensive systematic review and meta-analysis.

Authors:  K Munkholm; M Vinberg; L V Kessing
Journal:  Mol Psychiatry       Date:  2015-07-21       Impact factor: 15.992

Review 6.  Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment.

Authors:  Nishit Pathak; Sunil Kumar Vimal; Ishi Tandon; Lokesh Agrawal; Cao Hongyi; Sanjib Bhattacharyya
Journal:  Metab Brain Dis       Date:  2021-11-01       Impact factor: 3.584

Review 7.  A developmental neuroscience approach to the search for biomarkers in autism spectrum disorder.

Authors:  Kandice J Varcin; Charles A Nelson
Journal:  Curr Opin Neurol       Date:  2016-04       Impact factor: 5.710

Review 8.  Investigation of the Molecular Role of Brain-Derived Neurotrophic Factor in Alzheimer's Disease.

Authors:  Pragya Girotra; Tapan Behl; Aayush Sehgal; Sukhbir Singh; Simona Bungau
Journal:  J Mol Neurosci       Date:  2021-08-23       Impact factor: 3.444

9.  Neurocognitive endophenotypes in pediatric OCD probands, their unaffected parents and siblings.

Authors:  Amitai Abramovitch; Alessandro S De Nadai; Daniel A Geller
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2021-02-18       Impact factor: 5.201

Review 10.  Consensus on nomenclature for clinical staging models in bipolar disorder: A narrative review from the International Society for Bipolar Disorders (ISBD) Staging Task Force.

Authors:  Ralph Kupka; Anne Duffy; Jan Scott; Jorge Almeida; Vicent Balanzá-Martínez; Boris Birmaher; David J Bond; Elisa Brietzke; Ines Chendo; Benicio N Frey; Iria Grande; Danella Hafeman; Tomas Hajek; Manon Hillegers; Marcia Kauer-Sant'Anna; Rodrigo B Mansur; Afra van der Markt; Robert Post; Mauricio Tohen; Hailey Tremain; Gustavo Vazquez; Eduard Vieta; Lakshmi N Yatham; Michael Berk; Martin Alda; Flávio Kapczinski
Journal:  Bipolar Disord       Date:  2021-07-23       Impact factor: 5.345
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.